Clinical Trials Browser

Has results × eribulin × Gynecologic × Clear all

NCT01676818 2025-11-06

Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer

Phase 2 Completed

32 enrolled 17 charts

Uterine Cervical Neoplasms

NCT00334893 2017-11-29

Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Phase 2 Completed

74 enrolled 7 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms